What's New
- October 2024
- FDA approves GE Healthcare's Flyrcado™ (F-18 flurpiridaz injection) for PET myocardial perfusion imaging
- April 2024
- Curium I-123 ioflupane now available for Friday patient use
- February 2024
- Lantheus has discontinued Azedra® (I-131 iobenguane)
- January 2024
- NDC table updated
- December 2023
- FDA approves Jubilant Radiopharma's Kit for the Preparation of Tc-99m Sulfur Colloid
- November 2023
- Sun Radiopharma has discontinued production of its Sestamibi kit until further notice.
- Netspot™ is now approved for use as a multi-dose kit
- October 2023
- FDA approves Cyclopharm's Technegas® (kit for the preparation of technetium Tc 99m-labeled carbon inhalation aerosol)
- NorthStar Medical Radioisotopes will suspend manufacturing and commercialization of Mo-99 by the end of 2023.
- June 2023
- MAIA Pharmaceuticals announces its Sincalide for Injection has received FDA approval and is available for shipping.
- May 2023
- FDA approves Blue Earth Diagnostics' POSLUMA® (Flotufolastat F-18 Injection), a PSMA-targeted PET agent
- Jubilant Radiopharma announces availability of Kit for the Preparation of Technetium Tc-99m Mertiatide. See letter from manufacturer.
- April 2023
- All Lantheus TechneLite® (Technetium Tc 99m Generator) units are now 100% low-enriched uranium (LEU) generators. See letter from manufacturer.
- March 2023
- MAA Dose Particle Calculator has been updated to include particle calculations for doses 0 to 24 hours post-calibration
- November 2022
- DaTscan™ (I-123 ioflupane) indication expanded to include use in patients with suspected Dementia with Lewy Bodies (DLB). See Press Release.
- September 2022
- Lantheus discontinues all Ga-67 and Tl-201 products. See letter from manufacturer.
- Nonradioactive Adjuncts updated
- June 2022
- NDC table updated
- May 2022
- GE Healthcare's Myoview™ (kit for the preparation of Tc-99m tetrofosmin) now available in 10 mL vials in addition to 30 mL vials
- April 2022
- FDA approves Curium's I-123 ioflupane (a generic for GE Healthcare's DaTscan™)
- March 2022
- FDA approves Pluvicto™ (Lu-177 vipivotide tetraxetan) for treatment of progressive, PSMA-positive metastatic castration-resistant prostate cancer. FDA also approved a complementary diagnostic imaging agent, Locametz® (kit for the preparation of Ga-68 gozetotide injection), for the identification of PSMA-positive lesions.
- Lantheus announces it will discontinue production of Tl-201 and Ga-67 in late 2022. See letter from manufacturer.
- February 2022
- December 2021
- FDA approves Telix’s prostate cancer imaging product, Illuccix® (kit for the preparation of Ga-68 gozetotide injection)
- October 2021
- Quadramet (Sm-153 lexidronam) is discontinued. See letter from manufacturer.
- June 2021
- GE Healthcare's Tl-201 is discontinued. See letter from manufacturer.
- Lymphoseek® pediatric indication receives FDA approval
- May 2021
- FDA approves PYLARIFY® (F-18 piflufolastat), a PSMA-targeted PET agent
- Site updated to include recently approved PET radiopharmaceuticals: Tauvid™ (F-18 flortaucipir) and F-18 fluorodopa
- September 2020
- Curium announces FDA approval of Detectnet™ (copper Cu-64 dotatate), a PET agent indicated for the localization of somatostatin receptor positive neuroendocrine tumors in adult patients.
- June 2020
- Sun Radiopharma announces availability of Kit for the Preparation of Technetium Tc-99m Mertiatide
- Curium announces packaging change to Technescan™ HDP. Vials will be 10 mL instead of 6 mL. See customer letter.
- May 2020
- FDA approves Cerianna™ (F-18 fluoroestradiol) for use in PET imaging for the detection of estrogen receptor-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer.
- March 2020
- February 2020
- International Isotopes Inc. receives FDA approval for its I-131 product.
- Temporary changes to availability of In-111 DTPA. See customer letter with amended manufacturing schedule.
- December 2019
- BWX Technologies announces its In-111 Oxyquinolone (oxine) has received FDA approval and is available in the United States.
- November 2019
- FDA approves Q BioMed's Sr-89 Chloride for the relief of bone pain in patients with painful skeletal metastases. Product website: strontium89.com
- September 2019
- NDC table on this site has been revised
- August 2019
- FDA approves University of Iowa's Ga-68 DOTATOC Injection, a PET imaging agent used to assess neuroendocrine tumors.
- Customer letter from GE Healthcare announcing changes to In-111 DTPA product container and shielding
- July 2019
- Important safety information: "Open in a well-ventilated hood shipments of DraxImage Sodium Iodide I-131 Capsules, Diagnostic shipped without charcoal bags" See letter from manufacturer.
- May 2019
- Customer letter from Curium discussing changes to their product packaging, labels, and inserts
- February 2019
- New Ceretec™ product with a cobalt chloride stabilizer solution is now available from GE Healthcare. Ceretec™ packaged with methylene blue will be discontinued 31 MAR 2019. See letter from manufacturer for product comparison.
- January 2019
- Pharmalucence announced they will no longer manufacture Hepatolite® Kit for the Preparation of Technetium Tc-99m Disofenin for Injection. The final lot expires 30 SEP 2019.
- December 2018
- Drytec™ technetium Tc-99 generators are no longer available in the United States as of 17 DEC 2018.
- October 2018
- GE Healthcare will no longer manufacture Metastron™ (Sr-89 chloride) beginning 17 DEC 2018. See letter from manufacturer.
- July 2018
- FDA approves Azedra® (I-131 iobenguane)
- May 2018
- Aytu BioScience discontinues ProstaScint® (capromab pendetide) Kit. See letter from manufacturer.
- Curium discontinues Sodium Iodide I-131 Solution and Sodium Iodide I-131 Capsules. See letter from manufacturer.
- March 2018
- DRAX Exametazime™ now available in the United States
- February 2018
- FDA approves NorthStar Medical Radioisotopes' RadioGenix™ System, a Tc-99m generator using non-uranium sourced Mo-99.
- January 2018
- FDA approves AAA's Lutathera® (Lu-177 dotatate) for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors.
- Temporary importation of Tc-99m succimer (DMSA) to address drug shortage issues. Product is manufactured in Germany by ROTOP Pharmaka GmbH for Theragnostics. FDA has authorized importation and distribution, but the product is not FDA approved. See letter for DMSA product comparison table and ordering information.
- December 2017
- DRAXIMAGE® DTPA receives FDA approval for new pulmonary indications.
- October 2017
- The shelf life of DRAXIMAGE® MAA has increased from 6 hours to 12 hours post-reconstitution.
- August 2017
- The American College of Radiology (ACR) published revisions to Nuclear Medicine Practice Parameters. “Clinical Guidelines” sections on this site have been updated for the following radiopharmaceuticals: F-18 FDG, F-18 sodium fluoride, I-123 ioflupane, N-13 ammonia, Rb-82 chloride, Tc-99m disofenin, Tc-99m DTPA, Tc-99m HDP, Tc-99m MAG3, Tc-99m MDP, Tc-99m mebrofenin, Tc-99m sestamibi
- April 2017
- IBA Molecular purchases Mallinckrodt Nuclear Medicine. Now called Curium. www.curiumpharma.com
- March 2017
- Kinevac® (sincalide) shortage announced
- February 2017
- Mallinckrodt I-131 sodium iodide availability update
- December 2016
- Essential tips for using TechneLite® Tc-99m generator provided by Lantheus Medical Imaging. The letter offers guidance on how to proceed in a situation where the eluted Tc-99m activity is lower than expected, has partial volume, or no eluate is recovered.
- October 2016
- FDA approves RUBY-Fill® (Rubidium-82 generator and elution system)
- Mallinckrodt I-131 sodium iodide availability update
- August 2016
- HICON® Package Insert Update. Line added to Section 16.2 - Storage: "Discard unused capsules after all Sodium Iodide I-131 Solution has been dispensed or expired. New blister packages of hard gelatin capsules are provided with each new shipment of HICON®."
- July 2016
- An updated joint ASNC Imaging Guidelines and SNMMI Procedure Standard for PET nuclear cardiology procedures has just been published addressing the areas of PET myocardial perfusion and metabolism clinical imaging.
- DMSA Supply Update. Production suspended indefinitely.
- June 2016
- FDA approves Netspot™ (Ga-68 dotatate)
- May 2016
- FDA approves Axumin™ (F-18 fluciclovine)
- April 2016
- Jubilant DraxImage announced they will add a new production day for HICON™ I-131 sodium iodide solution beginning in May, 2016. A Saturday-calibrated lot will be manufactured and shipped on Mondays for delivery on Tuesdays (4 days pre-cal). They will continue to offer Sunday and Monday calibrated lots.
- Mallinckrodt changed the calibration day of In-111 chloride from Friday to Saturday. The product still expires on Monday.
- March 2016
- Letter from Bayer Healthcare Pharmaceuticals Subject: Xofigo® (Radium-223 dichloride) Implementation of NIST standard reference material change for quantifying the radioactivity of radium-223, and updated corresponding label information.